MBK Partners has acquired a 99.5 percent stake in Medit, a Seoul-based 3D dental scanner and solutions provider, from its largest shareholder, Unison Capital for 2.4 trillion won.
The acquisition took place a month after MBK was selected as the preferred bidder over the world's renowned private equity and investment firms, such as Carlyle, KKR, and Blackstone.
Medit founder Jang Min-ho and the firm's specially related parties also agreed to reinvest a considerable amount of revenue into the company. They will remain as joint investors with MBK. The deal is expected to close sometime around the first quarter of 2023.
The acquisition took place amid projections of the dental scanner market here and abroad growing 30 percent each year until 2027.
Medit is a global leader in the market for dental scanner solutions. The company secured a market share of 22 percent in 2020, and the portion rose to 24 percent this year.
The Korean firm started expanding its global footing in the industry from 2018 and has so far established branches in major countries such as the United States, Germany and China. The company runs 230 dealerships in around 100 countries across the globe.
Medit generated sales of 190.5 billion won last year, but this year's sales are estimated to have soared to around 270 billion won.
The dental scanner industry was an oligopoly market, with a group of top five companies accounting for more than 85 percent of the total market share. But the investment banking industry forecasts Medit and 3Shape to continue to expand their dominance in the industry and intensify a two-way rivalry.


Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Delivery Hero Sells Taiwan Foodpanda to Grab for $600 Million in Debt-Reduction Push
Australia's Inflation Eases in February but Core Pressures Persist
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict
Middle East War Rattles Global Markets as Oil Tops $100 and Dollar Surges
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Gold Prices Surge on U.S.-Iran Ceasefire Reports
Oil Prices Plunge Over 6% as Middle East Ceasefire Hopes Ease Supply Fears
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
Citi Names Eric Farina and Rob Cascarino to Lead Global Infrastructure Financing Group
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit 



